CDC May Get New Leader as Officials Consider Erica Schwartz
via HealthDayTHURSDAY, April 16, 2026 — Federal health officials are considering Dr. Erica Schwartz to lead the U.S. Centers for Disease Control and Prevention (CDC), according to people familiar with the discussions.
The decision is not yet final and would still need approval from President Donald Trump. It’s also not clear whether the administration will move forward with Schwartz or consider other candidates.
Schwartz was recommended by the U.S. Department of Health and Human Services (HHS).
A White House spokesperson, however, told NBC News that, “any reporting about personnel decisions, unless officially announced by the White House, should be considered baseless speculation.”
The CDC has been without a permanent director since August, following numerous leadership changes.
An earlier nominee, Dr. Dave Weldon, a former U.S. representative from Florida, was withdrawn in March 2025 amid concerns about Senate confirmation. Another official, scientist Susan Monarez, temporarily led the agency before being fired after disagreements over vaccines.
More recently, Dr. Jay Bhattacharya has overseen the CDC while also leading the National Institutes of Health. He replaced Jim O’Neill, who served as the CDC acting director for several months, NBC News reported.
Schwartz previously served as deputy surgeon general during Trump’s first term and has more than 20 years of service across the U.S. Navy, Public Health Service Commissioned Corps and U.S. Coast Guard.
She holds degrees in engineering, medicine, public health and law, NBC News reported.
If chosen, Schwartz would take over at a time of ongoing tension.
Last month, a federal judge blocked several changes to the childhood vaccination schedule made under U.S. Health Secretary Robert F. Kennedy Jr.
The ruling also paused decisions by the CDC’s vaccine advisory panel, known as the Advisory Committee on Immunization Practices.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-17 02:06
Read more
- Long COVID Linked to Heart Health Risks
- $3M Verdict Links Social Media to Anxiety and Depression
- Rhythm Pharmaceuticals Announces FDA Approval of Imcivree (setmelanotide) for Patients with Acquired Hypothalamic Obesity
- New Technologies Make Lung Cancer Diagnosis, Treatment Quicker and Safer
- FDA Grants Accelerated Approval for Kresladi for the Treatment of Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
- Direct-Acting Antiviral Prescribing for Hep C Peaked in 2015, Then Declined
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions